The effect of narrowband ultraviolet B phototherapy on antinuclear antibody status: A case‐control study

Kutlu, Ömer; Çetinkaya, Pınar Özdemir; Karaosmanoğlu, Nermin; Karaaslan, Engin; Nalbant, Esra Kiratli; Ekşioğlu, Meral

doi:10.1111/phpp.12601

Cited by 1 publication

(2 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Routine ANA screening before vitiligo phototherapy therefore is not recommended unless clinical symptoms of other autoimmune diseases are present, and if a patient is showing new-onset photosensitivity after initiation of NBUVB. 3,[163][164][165]…”

Section: Phototherapy and Screening For Anti-nuclear Antibodies In Pa...mentioning

confidence: 99%

“…Also, prior ANA positivity wasn't linked to phototoxic reactions or predictive of development of SLE in vitiligo patients undergoing phototherapy. Routine ANA screening before vitiligo phototherapy therefore is not recommended unless clinical symptoms of other autoimmune diseases are present, and if a patient is showing new‐onset photosensitivity after initiation of NBUVB 3,163–165 …”

Section: Miscellaenousmentioning

confidence: 99%

See 1 more Smart Citation

Phototherapy for vitiligo: A narrative review on the clinical and molecular aspects, and recent literature

Bishnoi,

Parsad

2024

Photoderm Photoimm Photomed

View full text Add to dashboard Cite

BackgroundVitiligo is characterized by depigmented patches resulting from loss of melanocytes. Phototherapy has emerged as a prominent treatment option for vitiligo, utilizing various light modalities to induce disease stability and repigmentation.Aims and MethodsThis narrative review aims to explore the clinical applications and molecular mechanisms of phototherapy in vitiligo.Results and DiscussionThe review evaluates existing literature on phototherapy for vitiligo, analyzing studies on hospital‐based and home‐based phototherapy, as well as outcomes related to stabilization and repigmentation. Narrowband ultra‐violet B, that is, NBUVB remains the most commonly employed, studied and effective phototherapy modality for vitiligo. Special attention is given to assessing different types of lamps, dosimetry, published guidelines, and the utilization of targeted phototherapy modalities. Additionally, the integration of phototherapy with other treatment modalities, including its use as a depigmenting therapy in generalized/universal vitiligo, is discussed. Screening for anti‐nuclear antibodies and tailoring approaches for non‐photo‐adapters are also examined.ConclusionIn conclusion, this review provides a comprehensive overview of phototherapy for vitiligo treatment. It underscores the evolving landscape of phototherapy and offers insights into optimizing therapeutic outcomes and addressing the challenges ahead. By integrating clinical evidence with molecular understanding, phototherapy emerges as a valuable therapeutic option for managing vitiligo, with potential for further advancements in the field.

show abstract

Section: Phototherapy and Screening For Anti-nuclear Antibodies In Pa...mentioning

confidence: 99%

Section: Miscellaenousmentioning

confidence: 99%

Phototherapy for vitiligo: A narrative review on the clinical and molecular aspects, and recent literature

Bishnoi,

Parsad

2024

Photoderm Photoimm Photomed

View full text Add to dashboard Cite

show abstract

The effect of narrowband ultraviolet B phototherapy on antinuclear antibody status: A case‐control study

Cited by 1 publication

References 23 publications

Phototherapy for vitiligo: A narrative review on the clinical and molecular aspects, and recent literature

Phototherapy for vitiligo: A narrative review on the clinical and molecular aspects, and recent literature

Contact Info

Product

Resources

About